Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

373

HTML

2930

Figures (1-2)

232

Tables (1-4)

231

Sum=3766

Dec 21, 2012 (publication date) through Jan 23, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 21, 2012; 18(47): 6987-6995
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.6987

Full Size Figure Download Figure

Figure 1 Cumulative probabilities of virologic breakthrough in the two treatment groups.

Citation: Yun TJ, Jung JY, Kim CH, Um SH, An H, Seo YS, Kim JD, Yim HJ, Keum B, Kim YS, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS. Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B. World J Gastroenterol 2012; 18(47): 6987-6995
URL: https://www.wjgnet.com/1007-9327/full/v18/i47/6987.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i47.6987